about
Emerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseBiomarkers of Inflammation and Immune Function and Risk of Colorectal CancerIdentification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MSVedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.Can chronic gastritis cause an increase in fecal calprotectin concentrations?Soluble ST2: a new and promising activity marker in ulcerative colitis.Irritable bowel syndrome: diagnostic approaches in clinical practice.Myeloperoxidase-dependent lipid peroxidation promotes the oxidative modification of cytosolic proteins in phagocytic neutrophilsFecal calprotectin concentrations in healthy children aged 1-18 monthsCrohn's disease patients have more IgG-binding fecal bacteria than controls.Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid?Oral fluid-based biomarkers of alveolar bone loss in periodontitis.Therapeutic efficacy of intestinal and multivisceral transplantation: survival and nutrition outcome.Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the ColorectumClinical value of fecal calprotectin in determining disease activity of ulcerative colitisFecal calprotectin in juvenile idiopathic arthritis patients related to drug use.Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin.Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring.Assessment of disease activity in pediatric ulcerative colitis.Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.Fecal biomarkers in inflammatory bowel disease.Increased faecal calprotectin predicts recurrence of colonic diverticulitis.Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease.Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.Comparative Analysis of Calcium-Binding Myeloid-Related Protein-8/14 in Saliva and Serum of Patients With Periodontitis and Healthy Individuals.Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease
P2860
Q26768273-9F09A3DD-4247-493D-8FEB-5C8BDC0EBB25Q26796256-2DD27419-4389-4B9D-BDB2-F7352356B17AQ30481751-3DA29C99-11CF-406C-9448-98449538B2FAQ33607108-EC55B447-8749-4210-99E5-03781023AC8CQ33695435-21434292-BBCE-4290-B74D-5553751C4C57Q33998635-978F26B3-D2E3-49E3-8B6B-8E69D5904B18Q34975712-681105D1-3B8C-4908-80A7-898BB240A744Q35026362-ABD71890-98A0-4ED6-9042-480E8D5E663AQ35352142-9C56CA59-DCF8-44E8-A1C2-033CBB40DA25Q35572083-A2AAE79D-F6CF-4A0A-88D5-936983FC32F6Q35867246-FA1C3D12-1099-4AD8-96AC-287820499840Q36245790-187BAC7E-565E-4217-BC62-B993B765A47BQ36792245-2F8E81A8-5006-4042-BBAA-E4371242E83CQ36955930-A30DA075-5C69-42C2-A8E5-9E5DE8F9FD1DQ37054085-EE541ABE-2B07-4CBD-BEF6-0653C17172F3Q37169713-3A717463-D5DA-41CE-957C-1964D62087F5Q37618733-85160E0C-52F5-4720-8B0A-7B3502FC9921Q38089781-8C82E805-0433-4442-848A-91EACC73782EQ38160764-F013D118-BC2A-4B3F-ACB1-CA8B39021AF2Q38825374-861C724C-453C-4445-A0EC-75138A11D7C7Q38896550-1F2C6EA2-3488-44D8-A708-28B71DC79533Q38977006-B91DD47D-1F3E-46BC-BB30-66D2D7C7CB1FQ40208211-69AB146F-7A7A-44B6-8DAD-422560ECCE6DQ41059819-9702E334-674F-4210-A82C-FC15AE52DE83Q41287600-3F60F40A-C8C1-468C-BE0F-888724274939Q41608430-B4CBB840-A608-4FA8-A093-18C73BACE2CDQ43773374-150818D8-1929-4633-A7DB-5DBE1D12B3F7Q43888872-FF594F34-FEE6-4515-AF08-C80855881830Q45294846-CAFE8524-6C52-4FC1-9062-362D64281BF1Q53496593-32539846-8405-4344-8B54-F8978B439BA9Q53914270-267CD8C1-618C-4E92-BD90-300DD875EAD6Q57804048-321E0D74-7818-41D6-8ED2-2A51B7BFE8DF
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Emerging role of calprotectin in gastroenterology.
@ast
Emerging role of calprotectin in gastroenterology.
@en
type
label
Emerging role of calprotectin in gastroenterology.
@ast
Emerging role of calprotectin in gastroenterology.
@en
prefLabel
Emerging role of calprotectin in gastroenterology.
@ast
Emerging role of calprotectin in gastroenterology.
@en
P2093
P2860
P1476
Emerging role of calprotectin in gastroenterology
@en
P2093
Andrew Poullis
Magne K Fagerhol
Russell Foster
P2860
P304
P356
10.1046/J.1440-1746.2003.03014.X
P577
2003-07-01T00:00:00Z